NovaBay Pharma reported net sales of $6.3 million in the fourth quarter of 2017, an increase of 55% from $4.1 million in 2016’s fourth quarter.
The company posted a net income of $0.8 million in the quarter, or $0.05 per share, compared to a net loss of $1.6 million, or $0.11 per share, in the fourth quarter of 2016, according to a press release.
General and administrative expenses for the quarter decreased from $2 million to $1.5 million, while sales and marketing costs increased from $3.1 million to $3.3 million.
(Read more...)
Uncategorized